TCRN Practice Exam 2026 – Complete Prep for Your Test

Warming blood products during fluid resuscitation of trauma patients is crucial for mitigating the risk of coagulopathies. When blood products are administered at cold temperatures, they can contribute to a decrease in core body temperature, leading to a phenomenon known as hypothermia-induced coagulopathy. Cold temperatures can impair platelet function and the activity of clotting factors, making it more difficult for the body to form clots and control bleeding. By warming blood products to near body temperature before administration, you help maintain normal physiological responses, thereby supporting effective hemostasis and reducing the likelihood of complications associated with coagulopathies.

The other options may not provide the same beneficial effect. High-dose vasopressors can lead to increased systemic vascular resistance but do not address the core issues associated with coagulopathy. The use of vasodilators might lower blood pressure but can further complicate hemorrhage control. Immediate surgery, while important in some trauma scenarios, is not a direct intervention during the resuscitation phase aimed specifically at preventing coagulopathy through fluid management. Thus, warming blood products is the indicated intervention to support coagulation during fluid resuscitation in trauma patients.